AlterG’s Revolutionary Anti-Gravity Treadmill Reaches A Wider Audience With The New M300 Series
AlterG, Inc., makers of the Anti-Gravity Treadmill, a revolutionary technology for rehabilitation and athletic training, today launched the AlterG M300. The M300 delivers the same anti-gravity technology originally developed at NASA and found in AlterG’s P200 series, only at a third of the price and with a sleek new design. This means the world’s only anti-gravity treadmill will be accessible to millions of people who are looking to rehabilitate more easily from injury or surgery or who want to train smarter. The AlterG M300 is optimized in form, function and price for physical therapy clinics, athletic training and leading fitness facilities.
Alter-G secures $8 million in series B financing from Versant Ventures
Alter‐G, a privately held medical device company based in Menlo Park California, has secured an $8 million round of series B funding from Versant Ventures. The proceeds will be used to continue to accelerate the company’s growth. Ross A. Jaffe, MD, Managing Director at Versant Ventures, will join Alter‐G’s board of directors.
Alter-G Anti-Gravity Treadmill Added at NovaCare Rehabilitation
NovaCare Rehabilitation, a division of Select Medical Corporation and the nation’s largest provider of outpatient physical therapy and rehabilitation services, is now the only facility in Pennsylvania to offer Alter-G’s innovative G-Trainer anti-gravity treadmill for athletic training and medical treatment programs.
Alter-G Announces $2.5M Series A Funding
New G-Trainer Model Broadens Adoption in Hospitals, Rehabilitation Centers and Athletic Facilities
Alter-G, Inc. today announced the availability of a new, lower-price G-Trainer model to be sold along with the existing G-Trainer Pro model, to enable a wider spectrum of medical and athletic facilities to acquire the technology. The company also introduced a low priced, full service and support rental program to facilitate short-term trial and long-term use with monthly rental fees as low as $1,350.
FDA Clears G-Trainer Anti-Gravity Treadmill for Medical Applications
The FDA has cleared Alter-G, Inc. for marketing the G-Trainer as a medical device. The G-Trainer is applicable for medical uses in rehabilitation after lower extremity injury or surgery, aerobic conditioning, weight control, gait training for neurological conditions, and strengthening and conditioning for older patients. In addition, during 2007 the G-Trainer has already seen overwhelming adoption as a training and conditioning tool that also reduces the risk of impact-related injuries while exercising.
Alter-G Names New CEO
Alter-G, Inc. today announced that Lars Barfod has been named as the company’s President and CEO. Barfod will also serve as a member of the board of directors.
G-Trainer User Joins 2008 US Olympic Marathon Team
Alter-G, Inc. congratulate Dathan Ritzenhein, an avid user of the G-Trainer, on his success at the U.S. Olympic Trials. Dathan Ritzenhein came in second at the U.S. Olympic Trials held in New York City on November 3, 2007 with a personal best time of 2:11:07. He’ll be joined in Beijing with Ryan Hall, who came in two minutes before Dathan, and Brian Sell who came in third.
Elite Athlete Podiatrist Talks About The G-Trainer at New York Athletic Club
Dr. Amol Saxena, podiatrist to elite athletes, including Olympians, joined by noted professional runner Shalane Flanagan, will be giving a presentation at the New York Athletic Club (NYAC) about the benefits of using a G-Trainer for injury prevention and training through injury recovery. The event will take place on November 3, 2007 from 2pm to 4pm.
